• Retatrutide - NuroCore
  • Retatrutide - NuroCore
  • Retatrutide - NuroCore
1 3

NuroCore

Retatrutide

Retatrutide

850.00 AED
1,676.00 AED 850.00 AED
Sale Sold out
Shipping calculated at checkout.
Size

Retatrutide is a cutting-edge triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors simultaneously. This next-generation compound is designed to deliver powerful synergistic effects for fat loss, improved insulin sensitivity, and enhanced metabolic health. Research indicates that Retatrutide may offer superior results in weight management, glucose regulation, and overall metabolic performance compared to single or dual agonists.

View full details


Concentration: Commonly10 mg, 20 mg, or 30 mg vials (lyophilized powder)

Composition: Synthetic 39–amino acid tri-agonist peptide

Formulation: Lyophilized acetate buffered polypeptide

Half-Life: Extended; engineered for once-weekly dosing in research

Primary Actions: GLP-1, GIP, GCGR agonism for metabolic studies


Shown to induce significant weight reduction in experimental studies.

Studied for reducing liver fat and improving metabolic markers.

Demonstrates enhanced efficacy vs single or dual incretin agonists.

Explored in obesity and diabetes research programs.


Reconstitute with bacteriostatic water (NuroCore standard).

Swirl gently until dissolved.

Handle only under sterile laboratory conditions.


Unreconstituted: Store at –20 °C.

Reconstituted: Refrigerate at 2–8 °C.

Appearance: Clear, colorless solution; discard if cloudy or particulate.


Category: Metabolic & Weight Management Research (NuroCore)

Use Case: Research into obesity, glycemic regulation, and metabolic optimization

Compliance Note: Classified strictly as a research compound

Other customers also bought

View all